257 related articles for article (PubMed ID: 20146261)
1. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
2. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
4. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
5. Promotion of liver regeneration by natural killer cells in a murine model is dependent on extracellular adenosine triphosphate phosphohydrolysis.
Graubardt N; Fahrner R; Trochsler M; Keogh A; Breu K; Furer C; Stroka D; Robson SC; Slack E; Candinas D; Beldi G
Hepatology; 2013 May; 57(5):1969-79. PubMed ID: 22898900
[TBL] [Abstract][Full Text] [Related]
6. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM
Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766
[TBL] [Abstract][Full Text] [Related]
7. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.
Hart ML; Gorzolla IC; Schittenhelm J; Robson SC; Eltzschig HK
J Immunol; 2010 Apr; 184(7):4017-24. PubMed ID: 20207994
[TBL] [Abstract][Full Text] [Related]
8. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
[TBL] [Abstract][Full Text] [Related]
9. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
[TBL] [Abstract][Full Text] [Related]
10. Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.
Pommey S; Lu B; McRae J; Stagg J; Hill P; Salvaris E; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
Hepatology; 2013 Apr; 57(4):1597-606. PubMed ID: 22829222
[TBL] [Abstract][Full Text] [Related]
11. CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.
Yoshida O; Kimura S; Jackson EK; Robson SC; Geller DA; Murase N; Thomson AW
Hepatology; 2013 Dec; 58(6):2163-75. PubMed ID: 23813862
[TBL] [Abstract][Full Text] [Related]
12. The impact of purinergic signaling on renal ischemia-reperfusion injury.
Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
[TBL] [Abstract][Full Text] [Related]
13. Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia.
Sun X; Imai M; Nowak-Machen M; Guckelberger O; Enjyoji K; Wu Y; Khalpey Z; Berberat P; Munasinghe J; Robson SC
Purinergic Signal; 2011 Dec; 7(4):427-34. PubMed ID: 21656186
[TBL] [Abstract][Full Text] [Related]
14. Deletion of cd39/entpd1 results in hepatic insulin resistance.
Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
[TBL] [Abstract][Full Text] [Related]
15. Purinergic dysregulation in pulmonary hypertension.
Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
[TBL] [Abstract][Full Text] [Related]
16. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury.
Crikis S; Lu B; Murray-Segal LM; Selan C; Robson SC; D'Apice AJ; Nandurkar HH; Cowan PJ; Dwyer KM
Am J Transplant; 2010 Dec; 10(12):2586-95. PubMed ID: 20840479
[TBL] [Abstract][Full Text] [Related]
17. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK
FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731
[TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
19. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-related apoptosis-inducing ligand on NK cells protects from hepatic ischemia-reperfusion injury.
Fahrner R; Trochsler M; Corazza N; Graubardt N; Keogh A; Candinas D; Brunner T; Stroka D; Beldi G
Transplantation; 2014 Jun; 97(11):1102-9. PubMed ID: 24804996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
